OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in HIV and AIDS is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Updates on bone health in people living with HIV: global impact, prediction tools, and treatment	96
Future options for long-acting HIV treatment and prevention	67
The sounds of silencing: dynamic epigenetic control of HIV latency	44
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission	33
HIV-associated tuberculosis in infants, children, and adolescents younger than 15 years: an update on the epidemiology, diagnosis, prevention, and treatment	29
Harnessing natural killer cells to target HIV-1 persistence	28
Editorial introductions	26
Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children	25
Editorial introduction	25
Statins for primary cardiovascular disease prevention among people with HIV: emergent directions	25
Development of screening assays for use of broadly neutralizing antibodies in people with HIV	21
A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation	20
Editorial introduction	20
Challenges towards an AIDS-free generation in Africa and Asia	20
Persistent elite controllers as the key model to identify permanent HIV remission	19
New latency-promoting agents for a block-and-lock functional cure strategy	18
Editorial introduction	18
Balancing polypharmacy and comorbidity management: cardiovascular health	17
Defining multimorbidity in people with HIV – what matters most?	17
The origins of new SARS-COV-2 variants in immuncompromised individuals	17
Loneliness and social isolation in people with HIV	17
Immunological effector mechanisms in HIV-1 elite controllers	17
Hepatitis co-infection in paediatric HIV: progressing treatment and prevention	16
Role of follicular homing natural killer cells in HIV infection	16
Viral and immune predictors of HIV posttreatment control	16

Editorial introduction	14
Impact of coronavirus disease 2019 on co-morbidities in HIV	14
Renal adverse drug reactions	12
Mpox and the impact on people with HIV	12
New vector and vaccine platforms: mRNA, DNA, viral vectors	12
The multifaceted nature of HIV tissue reservoirs	11
Obesity among women with HIV	11
Aging of adult lifetime survivors with perinatal HIV	11
Beyond criminalization: reconsidering HIV criminalization in an era of reform	10
Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels	10
The severity of COVID-19 across the spectrum of HIV	10
Host factors predisposing to kidney disease in people with HIV	10
Broadly neutralizing antibodies for HIV treatment and cure approaches	10
Metabolic dysfunction-associated steatotic liver disease in people with HIV	10
Editorial: New drugs for HIV: quo vadis?	10
Frailty in people with HIV: a geriatric syndrome approach to aging with HIV	10
Gender and sex considerations in HIV and bone health	10
HIV and cardiovascular disease: the role of inflammation	10
Strategies to target the central nervous system HIV reservoir	9
Persistent HIV-1 transcription during ART: time to reassess its significance?	8
Causes and outcomes of hepatic fibrosis in persons living with HIV	8
Editorial introduction	8
CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies	8
Editorial introductions	7
Innovative models of care supporting people aging with HIV	7
Guiding HIV-1 vaccine development with preclinical nonhuman primate research	7
HIV drug resistance in various body compartments	7
Editorial: Is it time to implement injectable antiretroviral treatments globally?	7
Editorial introduction	7
Editorial introductions	7
Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review	6
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development	6
HIV-1 subtypes and latent reservoirs	6
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?	6
Vaccinal effect of HIV-1 antibody therapy: dream or reality?	6
The pathogenesis of obesity in people living with HIV	6
Whole person HIV services: a social science approach	6
Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?	6